NESTcc adds laboratory and patient engagement experts to Governing Committee CONTEXT: The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), Continue Reading
Implications of the upcoming changes to French ATU (Autorisation Temporaire d’Utilisation) programme CONTEXT: From July of 2021manufacturers will be required to make all early access authorisation requests to the HAS Continue Reading
High-fidelity simulation model developed to assess impact of new technologies in critical care setting. CONTEXT: Not our usual RWR based story, but another example of the increasing use of “in-silico” Continue Reading
ALK present results of huge real-world evidence study on allergy immunotherapy (AIT) in asthma CONTEXT: ALK presented the results on the long term effects of allergy immunotherapy (AIT) on asthma Continue Reading
Are decentralised trials here to stay? Who knows…. CONTEXT: This is an opinion piece from Veradigm® asking whether decentralised trials will live on beyond the pandemic and as they have Continue Reading
One of Europe’s largest healthcare databases now includes Italy CONTEXT: Cegedim has now made it’s THIN® (The Health Improvement Network) database available in Italy with the inclusion of Italian patient Continue Reading
Retrospective real-world research study on multiple myeloma therapy in China CONTEXT: This abstract with reference to full article originally published in Leuk Lymphoma Journal is a retrospective analysis of newly Continue Reading
Retrospective review of healthcare costs associated with treatment-resistant depression (TRD) in Italy CONTEXT: Published in the ClinicoEconomics and Outcomes Research Journal, this retrospective review of around 6 million administrative database Continue Reading
French researchers first exposure to decentralised trials CONTEXT: Discussion article on one French company’s first experience with the concept of decentralised clinical trials and how they went about solving the Continue Reading
Symdeko (tezacaftor/ivacaftor) shows favourable results in Scottish real-world evidence study in cystic fibrosis CONTEXT: Publication of a real-world research study in cystic fibrosis in the European Journal of Hospital Pharmacy Continue Reading
